rs35273905
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001164507.2(NEB):c.17304G>A(p.Leu5768=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000901 in 1,613,746 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. L5768L) has been classified as Likely benign.
Frequency
Consequence
NM_001164507.2 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -21 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NEB | NM_001164507.2 | c.17304G>A | p.Leu5768= | synonymous_variant | 109/182 | ENST00000427231.7 | |
NEB | NM_001164508.2 | c.17304G>A | p.Leu5768= | synonymous_variant | 109/182 | ENST00000397345.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NEB | ENST00000397345.8 | c.17304G>A | p.Leu5768= | synonymous_variant | 109/182 | 5 | NM_001164508.2 | P5 | |
NEB | ENST00000427231.7 | c.17304G>A | p.Leu5768= | synonymous_variant | 109/182 | 5 | NM_001164507.2 | A2 |
Frequencies
GnomAD3 genomes AF: 0.00486 AC: 740AN: 152112Hom.: 4 Cov.: 32
GnomAD3 exomes AF: 0.00123 AC: 305AN: 248548Hom.: 1 AF XY: 0.00100 AC XY: 135AN XY: 134822
GnomAD4 exome AF: 0.000488 AC: 713AN: 1461516Hom.: 5 Cov.: 32 AF XY: 0.000428 AC XY: 311AN XY: 727020
GnomAD4 genome AF: 0.00487 AC: 741AN: 152230Hom.: 4 Cov.: 32 AF XY: 0.00470 AC XY: 350AN XY: 74428
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 05, 2019 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Nemaline myopathy 2 Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Dec 05, 2019 | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Mar 19, 2023 | - - |
NEB-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 29, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at